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When one completes a scientific study for a medical journal,
the article usually contains enough material for the reader to
judge its correctness. In general, an article should have enough
details so that others could repeat the study, if necessary, to
validate it. The peer review process is clearly different. It is
unclear that the same article undergoing peer review by
multiple different reviewers could necessarily end up with the
same editorial judgment. Our experience is that it is not
uncommon for seasoned excellent reviewers to have widely
varying recommendations regarding the suitability of a given
article for publication. All of us sense that there is a certain
capriciousness to the review process that is difficult to over-
come or quantitate. It raises the question of whether or not
one can do meaningful research on the process of peer review.
Once a year, JACC summarizes the important late–
breaking clinical trials (1) that were presented at the annual
ACC March meeting. This keeps the reader up-to-date in a
convenient way. Similarly, this Editor’s Page will review se-
lected articles on peer review as published in JAMA (2). These
articles were presented at the Third International Congress on
Peer Review in Biomedical Publication, held in September
1997 in Prague. Of 91 abstracts selected for presentation, 33
were published in JAMA (2). I am highlighting only a few in
this Editor’s Page that I thought would be of interest to authors
submitting to JACC.
A survey was made of authors in the Dutch Journal of
Medicine (3). Of the 352 respondents, 128 did not fulfill the
ICMJE criteria for authorship (4,5). Sixty percent of authors
did not know the ICMJE criteria for authorship. Do you (6)?
Over the last 20 years, the average number of authors in
articles published in the British Medical Journal (7) increased
from 3.21 (1975) to 4.46 (1995), primarily because of the rise in
authorship among professors and department chairpersons.
There was also a shift in authorship with more senior individ-
uals becoming first author. I do not believe that the latter is a
good trend.
A survey (8) of articles published in 1996 in three large
circulation journals (N Engl J Med, JAMA, and Annals of
Internal Medicine) and three smaller circulation journals
(Am J Cardiol, Am J Med, and Am J of Obstet & Gyn)
revealed that there was evidence of “honorary” authorship in
19% and “ghost” authorship in 11%. This was surprising,
because I assumed that practices such as “ghost” authorship
had disappeared.
The question of what makes a good review and reviewer (9)
was studied by evaluating the qualities of reviews prepared by
different reviewers. In a logistic regression analysis, the only
significant factor associated with a better review was reviewers
trained in epidemiology and statistics. Younger age was also
associated with higher quality reviews. Review quality in-
creased with time spent on the review up to three hours but not
beyond. Members of editorial boards had lower ratings on
their reviews. This result is in general concordance with our
impressions, except that our own editorial board seems to
supply first rate reviews.
Authors published in JACC frequently raise the question of
blinding the reviewers to the authors. A randomized study of
this procedure plus unmasking (revealing the reviewer’s iden-
tify to a co-reviewer) in manuscripts submitted to the British
Medical Journal (10) showed no editorially significant differ-
ence. This data may not reassure authors, but it is reassuring to
editors (like me) who are not using either process. In another
study by the British Medical Journal, neither blinding review-
ers to the authors nor requiring them to sign their reports had
any effect on detection rate of errors (11). Another report (12)
also concluded that masking reviewers to the identity of
authors did not improve the quality of reviews.
A review of manuscripts submitted to gastroenterology (13)
suggested that reviewers from the United States and outside
the United States evaluated non-United States papers similarly
and favored authors from the United States. There may be a
trend toward this in manuscripts submitted to JACC, although
we have not studied this in detail.
Another study searched MEDLINE from 1976 through
August 1997 and found a total of 235 articles that were
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retracted. These 235 articles were cited 2,034 times after the
retraction (14). This is obviously a major problem without any
easy solution.
I hope these excerpts of some articles on peer review are of
interest to both authors and readers. Those who wish to learn
more about this subject should read the entire July 15 1998
issue of JAMA (2). Clearly, editorial review is an “art,” not a
“science.”
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